Open day at the ISAE-SUPAERO campus
9.10.2018 11:00:00 EEST | Business Wire | Press release
As part of the Science Fair, organized this year around the theme of 'popular opinion', the ISAE-SUPAERO will open its entire campus to the public on Saturday, October 13 from 10.00 to 18.00. The event is aimed at families, businesses, partners, journalists or alumni (former students) and more than 3,000 people are expected to attend.
Several discussions will take place throughout the day to explain and debunk popular opinion with the general public: "Mechanics is not for girls", "We use only 10% of our brain", "Robots are smart", "Digital simulation is only for geeks", "Astronauts float because there's no gravity", "Laser beams are only used for fighting in science fiction movies", "Aircraft engines pollute the atmosphere and they're noisy", and many more.
Programme at the ISAE-SUPAERO:
➢ Lab visits and scientific demonstrations
➢ Tour of the aero-acoustic wind tunnel - the only facility of its kind in Europe
➢ Demonstrations
➢ Meetings with student clubs
➢ Activities for children
➢ Conference on "How does this aircraft fly safely?"
➢ "My student life at ISAE-SUPAERO" tour with an overview of the engineering curriculum, presentation of digital learning and guided tours of the student campus, sports facilities, residences and the university restaurant
➢ Boutique for kids: a chance to buy ISAE-SUPAERO souvenirs
➢ Show by the student band, Los Soupaéros
Practical information
Free entry - Address: 10 avenue Edouard Belin, 31055 Toulouse. Ring road (Rocade) exit 20. No parking in the vicinity; please use public transport (bus no. 27 and 37, get off at 'Laas CNRS' or 'Supaero'; Metro station 'Faculté de Pharmacie'). ID required for admission. Entrance on avenue Colonel Roche or avenue Edouard Belin. VélôToulouse stations nearby. Drinks and on-site catering available.
About the ISAE-SUPAERO
Global leader in higher education for aerospace engineering, ISAE-SUPAERO offers a unique range of training at the highest level: ISAE-SUPAERO engineer, CNAM-ISAE apprenticeship engineer, Master of Science in "Aerospace Engineering" (in English), 5 research-oriented master degrees, 15 specialized master degrees, 6 doctoral programs. The ISAE-SUPAERO learning community consists of more than 100 full-time professors and researchers and 1,700 students and doctoral students; it also relies on 1,800 lecturers from the professional world. More than 30% of its 650 annual graduates are international students. Its alumni network has more than 21,500 alumni on all continents.
The original source-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the source-language text, which is the only version of the text intended to have legal effect.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181009005484/en/
Contact information
OXYGEN TOULOUSE
Cécile MATHEY
cecilem@oxygen-rp.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 21:00:00 EEST | Press release
Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solution – uses digital twin technology to identify vulnerable customers and recommend explainable next-best actions for fro
Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o
Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a
DAYBU ® (trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 13:49:00 EEST | Press release
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating condition," said Catherine Owen Adams, Acadia’s Chief Executive Officer. “Our commitment is to make a meaningful difference in the lives of patients, caregivers, and the wider Rett com
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 12:18:00 EEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom